Sumichrast Martin A. 4

4 · cbdMD, Inc. · Filed Apr 21, 2021

Form 4

Period: 2012-04-19

DirectorChairman of the Board and CEO

Transactions

Award
Stock option
2021-04-19+250,000→ 250,000 total
Exercise: $3.39From: 2022-01-01Exp: 2027-01-01→ Common stock (250,000 underlying)
Award
stock option
2021-04-19+250,000→ 250,000 total
Exercise: $3.39From: 2023-01-01Exp: 2028-01-01→ Common stock (250,000 underlying)
Award
Stock option
2021-04-19+250,000→ 250,000 total
Exercise: $3.39From: 2024-01-01Exp: 2029-01-01→ Common stock (250,000 underlying)
Award
Restricted stock award
2021-04-19+250,000→ 250,000 total
Exercise: $0.00From: 2022-01-01Exp: 2022-01-01→ Common stock (250,000 underlying)
Award
Restricted stock award
2021-04-19+250,000→ 250,000 total
Exercise: $0.00From: 2024-01-01Exp: 2024-01-01→ Common stock (250,000 underlying)
Award
Restricted stock award
2021-04-19+250,000→ 250,000 total
Exercise: $0.00From: 2023-01-01Exp: 2023-01-01→ Common stock (250,000 underlying)

Footnotes (2)

[F1]Represents grants of stock options to the Reporting Person under the Issuer's 2021 Equity Compensation Plan (the "2021 Plan") pursuant to the terms and conditions of the Amended and Restated Executive Employment Agreement dated April 19, 2012 by and between the Issuer and the Reporting Person (the "Sumichrast Employment Agreement").
[F2]Represents grants of restricted stock awards to the Reporting Person under the 2021 Plan pursuant to the terms and conditions of the Sumichrast Employment Agreement.

Documents

1 file